5F-SDB-006

5F-SDB-006
Legal status
Legal status	US: possibly covered under the Federal Analogue Act in the United States and under similar bills in other countries;
Identifiers
	IUPAC name N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide;
CompTox Dashboard (EPA)	DTXSID601032523 ;
Chemical and physical data
Formula	C21H23FN2O
Molar mass	338.43 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(NCC1=CC=CC=C1)C2=CN(CCCCCF)C3=C2C=CC=C3;

5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC₅₀ of 50 nM for human CB₁ receptors, and 123 nM for human CB₂ receptors.^[1] It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1".^[2] 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA.

References

^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/acschemneuro.5b00107, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/acschemneuro.5b00107 instead.
^ Template:Cite DOI

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[1] Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1021/acschemneuro.5b00107, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1021/acschemneuro.5b00107 instead.

[2] Template:Cite DOI

[1]

[2]

See also

References